Abstract
The endogenous hallucinogen, N,N-dimethyltryptamine (DMT), was labeled with carbon-11 and its regional distribution in rat brain studied. [11C]DMT showed higher accumulation in the cerebral cortex, caudate putamen, and amygdaloid nuclei. Studies of the subcellular distribution of [11C]DMT revealed the specific localization in the fractions enriched with serotonin receptors only when a very low dose was injected into rats. The proportions of the radioactivity in receptor-rich fractions were greatly enhanced by pretreatment with the monoamine oxidase inhibitor, pargyline. Specific binding of [11C]DMT to serotonin receptors in dog brain was demonstrated by a positron emission tomographic study in which 5-methoxy-N,N-dimethyltryptamine caused approximately 20% displacement of the radioligand from the receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barker SA, Monti JA, Christian ST (1980) Metabolism of the hallucinogen N,N-dimethyltryptamine in the rat brain homogenates. Biochem Pharmacol 29:1049–1057
Bennett JP, Snyder SH (1975) Stereospecific binding of d-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin reseptors. Brain Res 94:523–544
Bennett JP, Snyder SH (1976) Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol 12:373–389
Berger G, Maziere M, Marazano C, Comar D (1978) Carbon-11 labeling of the psychoactive drug O-methyl-bufotenine and its distribution in the animal organism. Eur J Nucl Med 3:101–104
Berridge M, Comar D, Crouzel C, Baron J-C (1982) [11C]Labeled ketanserin: a selective serotonin S2 antagonist. J Labelled Compd Radiopharmacol 20:73–78
Biegon A, Rainbow TC, McEwen BS (1982) Quantitative autoradiography of serotonin receptors in the rat brain. Brain Res 242:197–204
Checkley SA, Murray RM, Oon MCH, Rodnight R, Birley JLT (1980) A longitudinal study of urinary excretion of N,N-dimethyltryptamine in psychotic patients. Br J Psychiatry 137:236–239
Fillion GMB, Rousselle JC, Fillion MP, Beaudoin DM, Coiny MR, Deniau JM, Jacob JJ (1977) High affinity binding of [3H]5-hydroxytryptamine to brain synaptosomal membranes: comparison with [3H]lysergic acid diethylamide binding. Mol Pharmacol 14:50–59
Gillin JC, Kaplan J, Stillman R, Wyatt RJ (1976) The psychedelic model of schiophrenia: the case of N,N-dimethyltryptamine. Am J Psychiatry 133:203–208
Glennon RA (1979) Serotonin receptor binding affinities of tryptamine analogues. J Med Chem 22:428–432
Ishiwata K, Ido T, Monma M, Murakami M, Fukuda H, Yamada K, Endo S, Yoshioka H, Sato S, Matsuzawa T (1981) Preparation and medical application of 45Ti. Cyric Annual Report 1981, Tohoku University, (Sendai, Japan), pp 164–171
Ishiwata K, Ido T, Yanai K, Kawashima K, Miura Y, Monma M, Watanuki S, Takahashi T, Iwata R (1985) Biodistribution of positron-emitting suicide inactivator of monoamine oxidase, [11C]pargyline, in mice and a rabbit. J Nucl Med 26:630–636
Kloster G, Hanus J, Voges R, Stöcklin G (1984) [11C]Mesulergin, a potential agent for mapping serotonin receptor: synthesis and animal experiments. J Labelled Compd Radiopharmacol 21:1155–1156
Konig FRG, Klippel RA (1967) The rat brain. A stereotaxic atlas of forebrain and lower parts of the brain stem. Robert E. Krieger. Huntington, New York
Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272:168–171
Narasimhachari N, Himwich HE (1973a) Gas chromatographicmass spectrometric identification of N,N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by single (selective) ion monitoring. Biochem Biophys Res Commun 55:1064–1071
Narasimhachari N, Himwich HE (1973b) GC-MS identification of bufotenine in urine samples from patient with schizophrenia or infantile autism. Life Sci 12:475–478
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol binding. Mol Pharmacol 16:687–699
Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science 212:827–829
Sangiah S, Gomez MV, Domino EF (1979) Accumulation of N,N-dimethyltryptamine in rat brain cortical slices. Biol Psychiatry 14:925–936
Takahashi T, Takahashi K, Ido T, Yanai K, Iwata R, Ishiwata K, Nozoe S (1985) [11C]Labeling of indolealkylamine alkaloids and the comparative study of their biodistributions. Int J Appl Radiat Isot 36:965–969
Yanai K, Takahashi K, Ishiwata K, Takahashi T, Kawashima K, Iwata R, Ido T (1984) [11C]Labeled indolealkylamines as potential serotonin1 receptor mapping agents: Synthesis and biodistribution. J Lab Compd Radiopharm 21 (11–12):1152–1154
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yanai, K., Ido, T., Ishiwata, K. et al. In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine. Eur J Nucl Med 12, 141–146 (1986). https://doi.org/10.1007/BF00276707
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00276707